Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Femasys (FEMY) Liabilities and Shareholders Equity (2024 - 2025)

Femasys' Liabilities and Shareholders Equity history spans 2 years, with the latest figure at $20.7 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 66.53% year-over-year to $20.7 million; the TTM value through Dec 2025 reached $64.1 million, down 11.84%, while the annual FY2025 figure was $20.7 million, 66.53% up from the prior year.
  • Liabilities and Shareholders Equity reached $20.7 million in Q4 2025 per FEMY's latest filing, up from $16.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $24.4 million in Q1 2024 to a low of $12.4 million in Q4 2024.